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Simple Method for Preparing and Quantifying Very-Low-Density Lipoprotein
M. Kohlmeier
A micromethod is described for isolating and quantifying human very-low-density lipoprotein (VLDL) from 0.1 mL of human serum, by which more than 100 samples can be processed in half a day with a standard ultracentrifuge. Replicate analysis of 10 normal and hyperlipemic samples gave median coefficients of variation of 11.7% for VLDL cholesterol, 5 
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Assay of very-low-density lipoprotein (VLDL) and its constituents is essential for many biochemical and clinical studies. Previous methods are indirect (1, 2) or involve laborious and time-consuming steps (3, 4). Moreover, most laboratories lack the capability for this kind of analysis, large amounts of sample (5 mL of plasma) are often required, and, most importantly, the composition and structure of lipoproteins may be altered during prolonged separations (5). To bypass some of these difficulties, I have modified a simple and rapidmicromethod forthe separationof lipoproteins (6) and adapted it for the simultaneous analysis of large numbers of fresh samples, rendering it more suitable for most clinical and epidemiological purposes.
Materials and Methods
Blood was sampled by cubital venipuncture from sitting subjects who had fasted overnight. For the micromethod the blood was allowed to stand for 40 mm at room temperature without an anticoagulant; the serum was then transferred into screw-capped vials and stored at 6 #{176}C until analysis that same day. Plasma for the conventional method (3) was similarly obtained, except that the fresh blood was transferred into tubes coated with dry EDTA (Sarstedt, Numbrecht, F.R.G.). 1.29 (5.1) Results Figure 2 shows the separation of the VLDL from the lowdensity plus high-density lipoprotein fractions that is achievable with the micro-ultracentrifugation procedure.
The densitometnc scan after agarose electrophoresis of fresh serum with increased VLDL concentration (hyperlipoproteinemia type IV) is compared with scans of the lipoprotein fractions that were obtained after ultracentrifugation.
Electrophoresis, which should detect the presence of less than 0.2% of VLDL and less than 0.1% of low-or high-density lipoprotein, revealed no cross contamination in top and bottom fractions.
I similarly treated VLDL as well as low-plus high-density lipoprotein fractions prepared from pooled human sera by conventional ultracentrifugation at d = 1.006 (3). When those components were rerun individually with the micromethod, electrophoresis of the resulting fractions again showed no VLDL in the bottom fraction, and no low-or high-density lipoprotein in the top fraction, leadingto the conclusion that cross contamination was <1% (Figure 3 ). 
